Our partnerships and clients also include key relationships with state departments of public health and government agencies, such as the U.S. Agency for Healthcare Research and Quality (AHRQ), the European Medicines Agency, the UK National Institute for Health and Clinical Excellence (NICE), and the World Health Organization (WHO).
We are also actively involved in supporting federal initiatives in regulating and promoting outcomes research. Outcome is an AHRQ DEcIDE Research Center. As a component of AHRQ’s Effective Healthcare initiative, our DEcIDE Center conducts accelerated practice studies about the outcomes, comparative clinical effectiveness, safety, and appropriateness of healthcare items and services.
Through Outcome’s role as a DEcIDE Center, the company was awarded the task order “Registries for Evaluating Patient Outcomes,” a project which led Drs Richard Gliklich and Nancy Dreyer as the principal investigators and senior editors to develop the landmark federal handbook “Registries for Evaluating Patient Outcomes: A User’s Guide,” originally released in May 2007, with a second edition released in September 2010.
Quintiles Outcome is also a European Medicine Agency PROTECT-EU partner and ENCePP research center. The PROTECT-EU project (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium) is a multi-national consortium of public, private and academic organizations across Europe that have come together to develop innovative methods in pharmacoepidemiology (PE) and pharmacovigilance (PV). PROTECT-EU looks at the limitations of current methods used in PV and PE in order to strengthen the monitoring of the benefit/risk balance of medicines marketed in Europe. The ENCePP (European Network of Centres for Pharmacoepidemiology and Pharmacovigilance) project is aimed at strengthening the monitoring of post-marketed medical products in Europe. The project’s goals include facilitating multi-center, independent, PASS studies focusing on a lack of efficacy.